Xylem Inc.
XYL Large CapIndustrials · Specialty Industrial Machinery
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Xylem Inc. en bref
Xylem Inc. (XYL) is currently trading at 97,20 € with a market capitalization of 23,1 Md €. The trailing P/E ratio stands at 27.71x, with a forward P/E of 18.28x. The 52-week range spans from 91,88 € to 134,63 €; the current price is 27.8% below the yearly high. Year-over-year revenue growth stands at +2.7%. The net profit margin stands at 10.79%.
💰 Dividende
Xylem Inc. pays an annual dividend of 1,50 € per share, representing a yield of 1.54%. The payout ratio stands at 40.55%.
📊 Avis des analystes
17 analystes évaluent Xylem Inc. (XYL) au consensus : Acheter. L'objectif de cours moyen est de 131,47 €, soit un potentiel de +35.26% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 108,21 € à 159,70 €.
Xylem Inc. : la thèse d'investissement en détail
Xylem Inc. (XYL) operates in the Industrials — specifically Specialty Industrial Machinery — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Wall Street consensus sits at Buy with an average price target implying roughly 35.26% upside from current levels — analyst sentiment is firmly constructive.
Le scénario baissier
Revenue growth has slowed to just 2.7%, which is below nominal GDP — the business is no longer outgrowing the broader economy.
À surveiller
- The forward P/E of 18.28x is meaningfully below the trailing 27.71x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 35.26% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Consensus des analystes : Buy
- Bilan solide avec faible endettement (D/E 18.35)
- Free cash flow positif
Aucun signal d'alerte significatif dans les indicateurs actuels.
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to market-like volatility.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Industrie stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Xylem Inc.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
